Cite
HARVARD Citation
Faivre-Finn, C. et al. (n.d.). 142: CONVERT – An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS). Lung cancer. pp. S64-. [Online].